SCHEMBL23773625

SCHEMBL23773625

Cn1cc(CCO[Si](C)(C)C(C)(C)C)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUT P33316 2/20 0.37
HDAC6 Q9UBN7 1/20 0.36
LNPEP Q9UIQ6 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KCNH2 Q12809 2/20 0.33
PDE10A Q9Y233 1/20 0.32
PDE8B O95263 1/20 0.32
SCN2A Q99250 1/20 0.31
CECR2 Q9BXF3 1/20 0.31
BAZ2B Q9UIF8 1/20 0.31
BAZ2A Q9UIF9 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
NPC1 O15118 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24508888 0.81 TSHR (0.36) DUTALDH1A1MEN1KMT2AHSD17B10
SCHEMBL14860590 0.75 MEN1 (0.40) HDAC6LNPEPALDH1A1MEN1KMT2A
SCHEMBL31358628 0.75 DUT (0.41) DUTALDH1A1KDM4E
SCHEMBL24197369 0.75 DUT (0.33) DUT
SCHEMBL9944488 0.72 KCNH2 (0.37) HDAC6ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL23793180 0.71 LNPEP (0.38) HDAC6LNPEPALDH1A1MEN1KMT2A
SCHEMBL23617844 0.71 MEN1 (0.36) HDAC6ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL26059803 0.71 DUT (0.35) DUTL3MBTL1
SCHEMBL9185281 0.70 IDO1 (0.42) DUTALDH1A1MEN1KMT2AHSD17B10
SCHEMBL15779296 0.70 DUT (0.35) DUTALDH1A1KCNH2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117624169-A 5-HT of the type 2A Receptor agonist, preparation method and application thereof 上海翊石医药科技有限公司 2024-03-01 CN disclosed
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
WO-2021163727-A1 PIKFYVE KINASE INHIBITORS AcuraStem Incorporated (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135152-A1 PIKFYVE KINASE INHIBITORS PIKFYVE, PIP5K1B, PIP5K1C DUT 2037/4885HDAC6 1045/4885LNPEP 3333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.